Department of Surgery, Kaiser Permanente Fontana Medical Center, 9961 Sierra Ave, Fontana, CA, 92335, USA.
Department of Surgery, Arrowhead Regional Medical Center, 400 N Pepper Ave, Colton, CA, 92324, USA.
Surg Endosc. 2022 Oct;36(10):7259-7265. doi: 10.1007/s00464-022-09109-w. Epub 2022 Feb 17.
The aim of this study is to determine whether regional abdominal wall nerve block is a superior to epidural anesthesia (EA) after hepatectomy.
Patients undergoing open hepatectomy in the NSQIP targeted file (2014-2016) were identified. Those with INR > 1.5, Platelets < 100, bleeding disorders, undergoing liver ablation without resection, and spinal anesthesia were excluded. Patients with regional abdominal wall nerve block (RAB), mostly transversus abdominis plane (TAP) block, were matched (1:1) to those undergoing EA using propensity scores to adjust for baseline differences.
Out of 1727 patients who met our inclusion criteria, 361 (21%) had RAB. Of whom 345 were matched (1:1) to those who underwent EA. The matched cohort was well-balanced regarding preoperative characteristics, extent of hepatectomy, concurrent ablations as well as biliary reconstruction. RAB was associated with shorter hospital stay (median: 6 days vs. 5 days, p = 0.007). Overall morbidity (44.1% vs. 39.4%, p = 0.217), serious morbidity (27% vs. 25.2%, p = 0.603), and mortality (2.6% vs. 2.3%, p = 0.806) were not different between the two groups. Individual complications, readmission rate, and blood transfusion were not different between the two groups.
Regional abdominal nerve block is associated with shorter hospital stay than epidural anesthesia without an increase in overall postoperative morbidity or mortality. RAB is a viable alternative anesthesia adjunct to EA in patients undergoing hepatectomy. However, given the retrospective nature of this study further studies comparing the modalities should be considered to definitively define the utility of RAB.
本研究旨在确定腹部区域神经阻滞是否优于硬膜外麻醉(EA)用于肝切除术。
从 NSQIP 目标文件(2014-2016 年)中确定接受开腹肝切除术的患者。排除 INR>1.5、血小板<100、出血性疾病、无肝切除术而行肝消融术以及接受脊髓麻醉的患者。接受区域腹壁神经阻滞(RAB)的患者(主要为腹横肌平面[TAP]阻滞),采用倾向评分进行 1:1 匹配,以与接受 EA 的患者进行比较,以调整基线差异。
在符合纳入标准的 1727 例患者中,有 361 例(21%)接受 RAB。其中 345 例与接受 EA 的患者进行了 1:1 匹配。匹配队列在术前特征、肝切除术范围、同时消融术以及胆道重建方面具有良好的均衡性。RAB 与较短的住院时间相关(中位数:6 天 vs. 5 天,p=0.007)。两组的总发病率(44.1% vs. 39.4%,p=0.217)、严重发病率(27% vs. 25.2%,p=0.603)和死亡率(2.6% vs. 2.3%,p=0.806)无差异。两组之间的个别并发症、再入院率和输血无差异。
与 EA 相比,RAB 不增加总体术后发病率或死亡率,但可缩短住院时间。在接受肝切除术的患者中,RAB 是 EA 的一种可行替代麻醉方法。但是,鉴于本研究的回顾性,应考虑进一步比较这些方法的研究来明确 RAB 的效用。